XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (26,804,394) $ (2,801,196)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Amortization of debt discount 817,118 324,448
Amortization of capitalized software 36,001
Amortization of intangibles 251,709 251,709
Acceleration of debt discount 500,145 4,536
Bad debt expense 58,470
Sales return and allowances 211,000 40,000
Inventory reserves 44,981
Operating Lease Payments 3,715
Liability to issue shares for services 32,500 16,000
Stock issued for services 35,200
Stock compensation expense 16,898,733 540,015
Changes in Assets and Liabilities    
Accounts receivable (586,364) (6,201)
Product deposit (943,388) (18,511)
Inventory (953,467) 275,091
Other current assets 72,893 154,057
Deferred revenue 303,064 158,255
Deferred tax liability (4,000)
Accounts payable and accrued expenses 4,426,702 1,158,293
Net cash (used in) provided by operating activities (5,595,382) 92,496
CASH FLOWS FROM INVESTING ACTIVITIES    
Cash paid for capitalized software costs (330,586)
Payment to seller for contingent consideration (400,000) (500,000)
Net cash used in investing activities (730,586) (500,000)
CASH FLOWS FROM FINANCING ACTIVITIES    
Cash proceeds from Series B Preferred Stock 2,892,500
Proceeds from convertible notes payable 2,350,000 1,126,250
Cash proceeds from sale of common stock 2,338,349
Cash proceeds from exercise of warrants  
Cash proceeds from exercise of options 300,400
Cash proceed from sale of warrants 25,000
Payment of debt issuance costs (15,000)
Distributions to non-controlling interest (121,223) (61,626)
Proceeds from note payable 242,000
Repayment of notes payable (2,498,808) (345,000)
Purchase of shares and warrants 349,999
Debt issuance costs (61,320)
Net cash provided by financing activities 6,135,981 1,008,303
Net (decrease) increase in cash (189,987) 600,799
Cash at beginning of the period 1,106,624 180,093
Cash at end of the period 916,637 780,892
Supplemental Disclosure of Cash Flow Information    
Cash paid during the period for interest 592,961 324,372
Issuance of company stock for investment in subsidiary 900,000
Cashless exercise of warrants 49,551
Deemed dividend from warrant price adjustments 1,216,021
Deemed distribution from warrants issued with Series B Preferred Stock 3,500,000
Stock yet to be issued for capitalized costs 40,000
Deemed distribution from down-round provision on unissued shares 194,022
Liability to issue common stock 76,348
Debt issuance costs for liability to issue shares 219,450
Conversion of convertible note payable and interest for Series B Preferred Stock 607,500
Stock issued for capitalized costs 12,675
Warrants issued in relation to debt $ 569,147